Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: a systematic review and economic evaluation

Bibliographic Details
Main Authors: C Green, J Dinnes, A Takeda, J Shepherd, D Hartwell, C Cave, E Payne, B Cuthbertson
Format: Article
Language:English
Published: NIHR Journals Library 2005-03-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta9110
_version_ 1819149390052327424
author C Green
J Dinnes
A Takeda
J Shepherd
D Hartwell
C Cave
E Payne
B Cuthbertson
author_facet C Green
J Dinnes
A Takeda
J Shepherd
D Hartwell
C Cave
E Payne
B Cuthbertson
author_sort C Green
collection DOAJ
first_indexed 2024-12-22T14:00:50Z
format Article
id doaj.art-0f42ae30a37e45f6a41270bf867d9430
institution Directory Open Access Journal
issn 1366-5278
language English
last_indexed 2024-12-22T14:00:50Z
publishDate 2005-03-01
publisher NIHR Journals Library
record_format Article
series Health Technology Assessment
spelling doaj.art-0f42ae30a37e45f6a41270bf867d94302022-12-21T18:23:25ZengNIHR Journals LibraryHealth Technology Assessment1366-52782005-03-0191110.3310/hta9110Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: a systematic review and economic evaluationC Green0J DinnesA TakedaJ ShepherdD HartwellC CaveE PayneB CuthbertsonSouthampton Health Technology Assessments Centre (SHTAC), University of Southampton, UKhttps://doi.org/10.3310/hta9110
spellingShingle C Green
J Dinnes
A Takeda
J Shepherd
D Hartwell
C Cave
E Payne
B Cuthbertson
Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: a systematic review and economic evaluation
Health Technology Assessment
title Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: a systematic review and economic evaluation
title_full Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: a systematic review and economic evaluation
title_fullStr Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: a systematic review and economic evaluation
title_full_unstemmed Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: a systematic review and economic evaluation
title_short Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: a systematic review and economic evaluation
title_sort clinical effectiveness and cost effectiveness of drotrecogin alfa activated xigris r for the treatment of severe sepsis in adults a systematic review and economic evaluation
url https://doi.org/10.3310/hta9110
work_keys_str_mv AT cgreen clinicaleffectivenessandcosteffectivenessofdrotrecoginalfaactivatedxigrisforthetreatmentofseveresepsisinadultsasystematicreviewandeconomicevaluation
AT jdinnes clinicaleffectivenessandcosteffectivenessofdrotrecoginalfaactivatedxigrisforthetreatmentofseveresepsisinadultsasystematicreviewandeconomicevaluation
AT atakeda clinicaleffectivenessandcosteffectivenessofdrotrecoginalfaactivatedxigrisforthetreatmentofseveresepsisinadultsasystematicreviewandeconomicevaluation
AT jshepherd clinicaleffectivenessandcosteffectivenessofdrotrecoginalfaactivatedxigrisforthetreatmentofseveresepsisinadultsasystematicreviewandeconomicevaluation
AT dhartwell clinicaleffectivenessandcosteffectivenessofdrotrecoginalfaactivatedxigrisforthetreatmentofseveresepsisinadultsasystematicreviewandeconomicevaluation
AT ccave clinicaleffectivenessandcosteffectivenessofdrotrecoginalfaactivatedxigrisforthetreatmentofseveresepsisinadultsasystematicreviewandeconomicevaluation
AT epayne clinicaleffectivenessandcosteffectivenessofdrotrecoginalfaactivatedxigrisforthetreatmentofseveresepsisinadultsasystematicreviewandeconomicevaluation
AT bcuthbertson clinicaleffectivenessandcosteffectivenessofdrotrecoginalfaactivatedxigrisforthetreatmentofseveresepsisinadultsasystematicreviewandeconomicevaluation